Effectiveness of implantable defibrillators for preventing arrhythmic events and death
- 3 May 2003
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (9), 1573-1582
- https://doi.org/10.1016/s0735-1097(03)00253-5
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Role of the Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac DeathAnnals of Internal Medicine, 2000
- Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestationsThe American Journal of Cardiology, 1999
- Management of Ventricular ArrhythmiasJAMA, 1999
- Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac DeathCirculation, 1997
- Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trialsThe Lancet, 1997
- Adverse Effects of Low Dose Amiodarone: A Meta-AnalysisJournal of the American College of Cardiology, 1997
- Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmiasProgress in Cardiovascular Diseases, 1996
- Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: An antagonist's viewpointProgress in Cardiovascular Diseases, 1996
- Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular ArrhythmiaNew England Journal of Medicine, 1995
- Randomised trial of low-dose amiodarone in severe congestive heart failureThe Lancet, 1994